✦ LIBER ✦

Rapid recovery of hematopoiesis in patients given high-dose chemotherapy followed by infusion of refrigerated unprocessed autologous bone marrow and peripheral blood

✍ Scribed by S Aggarwal; B Singh; S.K Sood; V.P Kumra; S.P Byotra; V.P Sachar; R.K Saran

Book ID: 117229812
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 61 KB
Volume: 32
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(00)01743-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of combined autologous of bone

Efficacy of combined autologous of bone marrow and peripheral blood The International Journal of Cell Cloning on hematological recovery following high-dose chemotherapy

✍ T. Mukaiyama; M. Ogawa; Bone Marrow 📂 Article 📅 1992 🏛 AlphaMed Press 🌐 English ⚖ 160 KB

High-dose chemotherapy with etoposide, c

High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study

✍ Ibrahim, Amad; Zambon, Edmilson; Bourhis, Jean H.; Ostronoff, Maurice; Beaujean, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 844 KB

A phase I/II study of high-dose cyclopho

A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies

✍ A. M. Hussein; William P. Petros; Maureen Ross; James J. Vredenburgh; Mary Lou A 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 300 KB

Intensive chemotherapy with high doses o

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

✍ M. H. Gaspard; D. Maraninchi; A. M. Stoppa; J. A. Gastaut; G. Michel; N. Tubiana 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 688 KB

Twenty-six patients (median age 33 years) with poor-risk malignancies were treated with high-dose combination chemotherapy associating BCNU-etoposide-cytosine arabinoside and melphalan (BEAM) followed by autologous bone marrow transplantation (ABMT). Twenty-one patients had malignant lymphomas, thre

Hematopoietic recovery following high-do

Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF

✍ M. J. Laughlin; G. Kirkpatrick; N. Sabiston; W. Peters; J. Kurtzberg 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 879 KB